CRAIG WIGGINS: Open Payments
NPI 1386088649 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,356 in 175 payments from 22 companies in 2025. Trend: 2023 $2,253 · 2024 $3,308 · 2025 $3,356
Food & beverage: $3,337Education: $19
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 15 | $417 |
| ABBVIE INC. | 22 | $398 |
| Novartis Pharmaceuticals Corporation | 24 | $359 |
| LEO Pharma Inc. | 6 | $277 |
| Incyte Corporation | 16 | $267 |
| UCB, Inc. | 18 | $238 |
| Regeneron Healthcare Solutions, Inc. | 10 | $228 |
| Organon LLC | 11 | $188 |
| Galderma Laboratories, L.P. | 12 | $186 |
| Botanix SB Inc | 11 | $154 |
Products named: DUPIXENT, OPZELURA, SKYRIZI, Bimzelx, ANZUPGO, NEMLUVIO, COSENTYX, XOLAIR.
Industry payments across AZ — which companies pay providers there.
